411529

L-carnitine promising effects in cisplatin-induced nephrotoxicity

Article

Last updated: 15 Feb 2025

Subjects

-

Tags

-

Abstract

Objective: This study aimed at exploring the therapeutic efficacy of L-Carnitine (LC) against cisplatin-induced nephrotoxicity (CIN) by assessing oxidative stress response, and relevant gene expression in rat kidney tissues. Methods: Rat CIN model was induced by intraperitoneal injection of Cisplatin (Cis). Eighteen male Sprague-Dawley mature rats with age (6 weeks) weighing 180 ± 20 gm were randomized to receive either control (saline), Cis or Cis + LC. Markers of oxidative stress (superoxide dismutase (SOD) and Malonaldehyde (MDA) and Bax and BCL-2 gene expression profiles were assessed thereafter.   Results: Cisplatin administration showed a marked increase in oxidative stress as evidenced by elevated MDA and diminished SOD levels, and changes in gene expressions of apoptosis-regulating genes (BCL2, BAX). Remarkably, treatment with LC normalized most parameters and achieving gene expression levels comparable to control groups. Conclusion: Our findings highlight the significant nephroprotective potential of LC against CIN, pivoting the way for bigger clinical studies and incorporation into clinical care guidelines.

DOI

10.21608/mjcc.2023.411529

Keywords

Cisplatin, Nephrotoxicity, L-carnitine, Oxidative Stress, Gene expression, Bcl-2, Bax, SOD, MDA

Volume

59

Article Issue

1

Related Issue

53775

Issue Date

2023-01-01

Receive Date

2025-02-13

Publish Date

2023-01-01

Page Start

46

Page End

50

Print ISSN

1687-5060

Online ISSN

2974-4938

Link

https://micc.journals.ekb.eg/article_411529.html

Detail API

http://journals.ekb.eg?_action=service&article_code=411529

Order

411,529

Type

Original Article

Type Code

3,440

Publication Type

Journal

Publication Title

Mansoura Journal of Chemistry

Publication Link

https://micc.journals.ekb.eg/

MainTitle

L-carnitine promising effects in cisplatin-induced nephrotoxicity

Details

Type

Article

Created At

15 Feb 2025